Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients

Oncology Reports

Volumn 16, Issue 5, 2006, Pages 1093-1098

  Sano, Masakazu ^a   Genkai, Nobuyuki ^a   Yajima, Naoki ^a   Tsuchiya, Naoto ^a   Homma, Junpei ^a   Tanaka, Ryuichi ^a   Miki, Toru ^b   Yamanaka, Ryuya ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Epithelial cell transforming gene 2; Glioma; siRNA

Indexed keywords

ECT2 PROTEIN, HUMAN; MESSENGER RNA; ONCOPROTEIN; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BRAIN TUMOR; CELL GROWTH; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

ADULT; AGED; BRAIN NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 35848937194     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.5.1093     Document Type: Article

References (19)

1. Stewart LA: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 359: 1011-1018, 2002.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E and Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005. (Pubitemid 40349501)
3. Miki T, Smith CL, Long JE, Eva A and Fleming TP: Oncogene ect2 is related to regulators of small GTP-binding proteins. Nature 362: 462-465, 1993. (Pubitemid 23107372)
4. Tatsumoto T, Xie X, Blumenthal R, Okamoto I and Miki T: Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis. J Cell Biol 147: 921-928, 1999.
5. Saito S, Liu XF, Kamijo K, Raziuddin R, Tatsumoto T, Okamoto I, Chen X, Lee CC, Lorenzi MV, Ohara N and Miki T: Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation. J Biol Chem 279: 7169-7179, 2004. (Pubitemid 38248864)
6. Van Aelst L and D'Souza-Schorey C: Rho GTPases and signaling networks. Gene Dev 11: 2295-2322, 1997. (Pubitemid 27408529)
7. Hall A: Rho GTPases and the actin cytoskeleton. Science 279: 509-514, 1998.
8. Etienne-Manneville S and Hall A: Rho GTPases in cell biology. Nature 420: 629-635, 2002. (Pubitemid 36764489)
9. Hara T, Abe M, Inoue H, Yu LR, Veenstra TD, Kang YH, Lee KS and Miki T: Cytokinesis regulator ECT2 changes its conformation through phosphorylation at Thr-341 in G2/M phase. Oncogene 25: 566-578, 2006. (Pubitemid 43164467)
10. Niiya F, Tatsumoto T, Lee KS and Miki T: Phosphorylation of the cytokinesis regulator ECT2 at G2/M phase stimulates association of the mitotic kinase Plk1 and accumulation of GTP-bound RhoA. Oncogene 25: 827-837, 2006. (Pubitemid 43237701)
11. Niiya F, Xie X, Lee KS, Inoue H and Miki T: Inhibition of cyclin-dependent kinase 1 induces cytokinesis without chromosome segregation in an ECT2 and MgcRacGAP-dependent manner. J Biol Chem 280: 36502-36509, 2005. (Pubitemid 41633924)
12. Prokopenko SN, Brumby A, O'Keefe L, Prior L, He Y, Saint R and Bellen HJ: A putative exchange factor for Rho1 GTPase is required for initiation of cytokinesis in Drosophila. Genes Dev 13: 2301-2314, 1999. (Pubitemid 29426733)
13. Somers WG and Saint R: A RhoGEF and Rho family GTPase-activating protein complex links the contractile ring to cortical microtubules at the onset of cytokinesis. Dev Cell 4: 29-39, 2003. (Pubitemid 36109144)
14. Kimura K, Tsuji T, Takada Y, Miki T and Narumiya S: Accumulation of GTP-bound RhoA during cytokinesis and a critical role of ECT2 in this accumulation. J Biol Chem 275: 17233-17236, 2000. (Pubitemid 30430753)
15. Echard A and O'Farrell PH: The degradation of two mitotic cyclins contributes to the timing of cytokinesis. Curr Biol 13: 373-383, 2003. (Pubitemid 36280454)
16. Kleihues P and Cavenee WK: World Health Organization Classification of Tumours of the Nervous System. WHO/IARC, Lyon, 2000.
17. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK and De Pinho RA: Malignant glioma: genetics and biology of a grave matter. Genes Dev 15: 1311-1333, 2001. (Pubitemid 32524640)
18. Roversi G, Pfundt R, Moroni RF, Magnani I, van Reijmersdal S, Pollo B, Straatman H, Larizza L and Schoenmakers EF: Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines. Oncogene 2005.
19. Yen CC, Chen YJ, Pan CC, Lu KH, Chen PC, Hsia JY, Chen JT, Wu YC, Hsu WH, Wang LS, Huang MH, Huang BS, Hu CP, Chen PM and Lin CH: Copy number changes of target genes in chromosome 3q25.3-qter of esophageal squamous cell carcinoma: TP63 is amplified in early carcinogenesis but downregulated as disease progressed. World J Gastroenterol 11: 1267-1272, 2005. (Pubitemid 40425907)